Morgan Stanley’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124M Buy
2,378,640
+628,897
+36% +$30.9M 0.01% 1389
2026
Q1
$82.5M Sell
1,749,743
-60,270
-3% -$2.99M 0.01% 1608
2025
Q4
$85.2M Buy
1,810,013
+513,376
+40% +$23.8M 0.01% 1585
2025
Q3
$54.5M Buy
1,296,637
+62,572
+5% +$2.51M ﹤0.01% 1941
2025
Q2
$45.3M Buy
1,234,065
+121,955
+11% +$4.05M ﹤0.01% 2012
2025
Q1
$33.7M Buy
1,112,110
+45,438
+4% +$1.31M ﹤0.01% 2182
2024
Q4
$30.3M Buy
1,066,672
+266,007
+33% +$7.16M ﹤0.01% 2328
2024
Q3
$20.9M Sell
800,665
-104,843
-12% -$2.04M ﹤0.01% 2762
2024
Q2
$13.2M Buy
905,508
+626,426
+224% +$8.85M ﹤0.01% 3092
2024
Q1
$4.12M Buy
+279,082
New +$3.84M ﹤0.01% 4064

Other funds holding AHR

Morgan Stanley's AHR Position: Q2 2026 in Review

Morgan Stanley increased its American Healthcare REIT (AHR) stake by 36% in Q2 2026, buying an estimated $30.9M and bringing the position to 2,378,640 shares worth $124M. The position accounts for 0.01% of the portfolio, ranked #1389.

Morgan Stanley first reported a position in AHR in Q1 2024 and has held it in 10 quarters since. 571 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • Morgan Stanley held 2,378,640 shares of American Healthcare REIT worth $124M as of Q2 2026.
  • Morgan Stanley bought 628,897 American Healthcare REIT shares in Q2 2026, an estimated $30.9M.
  • American Healthcare REIT made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1389 holding.
  • Morgan Stanley first reported a position in American Healthcare REIT in Q1 2024 and has held it in 10 quarters since.
  • 571 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.